Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 1
1970 1
1985 1
1986 1
1996 3
1999 2
2000 1
2003 1
2007 1
2008 3
2009 4
2010 9
2011 24
2012 18
2013 14
2014 12
2015 8
2016 6
2017 9
2018 5
2019 2
2020 4
2021 2
2022 2
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial.
Schoser B, Roberts M, Byrne BJ, Sitaraman S, Jiang H, Laforêt P, Toscano A, Castelli J, Díaz-Manera J, Goldman M, van der Ploeg AT, Bratkovic D, Kuchipudi S, Mozaffar T, Kishnani PS; PROPEL Study Group. Schoser B, et al. Lancet Neurol. 2021 Dec;20(12):1027-1037. doi: 10.1016/S1474-4422(21)00331-8. Lancet Neurol. 2021. PMID: 34800400 Clinical Trial.
104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07).
Schoser B, Kishnani PS, Bratkovic D, Byrne BJ, Claeys KG, Díaz-Manera J, Laforêt P, Roberts M, Toscano A, van der Ploeg AT, Castelli J, Goldman M, Holdbrook F, Sitaraman Das S, Wasfi Y, Mozaffar T; ATB200-07 Study Group. Schoser B, et al. J Neurol. 2024 May;271(5):2810-2823. doi: 10.1007/s00415-024-12236-0. Epub 2024 Feb 28. J Neurol. 2024. PMID: 38418563 Free PMC article. Clinical Trial.
Diet as a moderator in the association of sedentary behaviors with inflammatory biomarkers among adolescents in the HELENA study.
Arouca AB, Santaliestra-Pasías AM, Moreno LA, Marcos A, Widhalm K, Molnár D, Manios Y, Gottrand F, Kafatos A, Kersting M, Sjöström M, Sáinz ÁG, Ferrari M, Huybrechts I, González-Gross M, Forsner M, De Henauw S, Michels N; HELENA study group. Arouca AB, et al. Eur J Nutr. 2019 Aug;58(5):2051-2065. doi: 10.1007/s00394-018-1764-4. Epub 2018 Jul 4. Eur J Nutr. 2019. PMID: 29974229
Reliability and validity of a screen time-based sedentary behaviour questionnaire for adolescents: The HELENA study.
Rey-López JP, Ruiz JR, Ortega FB, Verloigne M, Vicente-Rodriguez G, Gracia-Marco L, Gottrand F, Molnar D, Widhalm K, Zaccaria M, Cuenca-García M, Sjöström M, De Bourdeaudhuij I, Moreno LA; HELENA Study Group. Rey-López JP, et al. Eur J Public Health. 2012 Jun;22(3):373-7. doi: 10.1093/eurpub/ckr040. Epub 2011 Apr 15. Eur J Public Health. 2012. PMID: 21498560
110 results